Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Uwe Siebert, M.D.

Title
Institution
Department
Address
Phone
Fax

Biography
awards and honors
2017
Award for Distinguished Service
2013
Leadership and Service Award
2012
David Sackett Award
2011
Award as Co-Chair of the ISPOR-SMDM Modeling Good Research Practices Task Force
2010
Leadership and Service Award
2009
Award for Best Short Course "Causal Inference and Causal Diagrams in Medical Decision Making"
2009
David Sackett Award
2008
ISPOR Leadership Pin
2008
ISPOR Distinguished Service Award
2008
ISPOR Board of Directors Service Award
2008
Best Publication in Journal for Internal Medicine in Hospital and Practice
2004
Award for Outstanding Short Course "Causal Inference and Causal Diagrams in Medical Decision Making"
2003
Award for Evidence-based Medicine
2000
German Award for Pain Research
1999
Paul Martini Research Award in Pharmacoepidemiology
1999
Spitzner-Award Physical and Rehabilitative Medicine
1998
Pain Research Award
1996
Fritz and Hildegard Berg Award for Public Health
1996
Bavarian Public Health Award
1980
Robert Bosch Science Award

Overview

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Gothe H, Matteucci Gothe R, Arvandi M, Hintringer K, Toell T, Oberaigner W, Rajsic S, Kugler J, Kiechl S, Willeit J, Siebert U. [Linkage of Clinical and Claims Data in the Evaluation of Post-Stroke Care - SeDaStro: Experiences from the Tyrolian StrokeCard Program]. Gesundheitswesen. 2020 Mar; 82(S 02):S122-S130. PMID: 32193880.
    Citations:    
  2. Lechner C, Schnaiter D, Siebert U, Böse-O'Reilly S. Effects of Motorcycle Noise on Annoyance-A Cross-Sectional Study in the Alps. Int J Environ Res Public Health. 2020 Feb 29; 17(5). PMID: 32121377.
    Citations:    
  3. Rochau U, Qerimi Rushaj V, Schaffner M, Schönhensch M, Stojkov I, Jahn B, Hubalewska-Dydejczyk A, Erlund I, Thuesen BH, Zimmermann M, Moreno-Reyes R, Lazarus JH, Völzke H, Siebert U. Decision-Analytic Modeling Studies in Prevention and Treatment of Iodine Deficiency and Thyroid Disorders: A Systematic Overview. Thyroid. 2020 Feb 26. PMID: 31964247.
    Citations:    
  4. Bose-O'Reilly S, Lettmeier B, Shoko D, Roider G, Drasch G, Siebert U. Infants and mothers levels of mercury in breast milk, urine and hair, data from an artisanal and small-scale gold mining area in Kadoma / Zimbabwe. Environ Res. 2020 Feb 20; 184:109266. PMID: 32126374.
    Citations:    
  5. Sroczynski G, Gogollari A, Kuehne F, Hallsson LR, Widschwendter M, Pashayan N, Siebert U. A SYSTEMATIC REVIEW ON COST-EFFECTIVENESS STUDIES EVALUATING OVARIAN CANCER EARLY DETECTION AND PREVENTION STRATEGIES. Cancer Prev Res (Phila). 2020 Feb 18. PMID: 32071120.
    Citations:    
  6. Stauder R, Lambert J, Desruol-Allardin S, Savre I, Gaugler L, Stojkov I, Siebert U, Chevrou-Séverac H. Patient-reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis. Eur J Haematol. 2020 Jan 27. PMID: 31985078.
    Citations:    
  7. Leitinger M, Trinka E, Zimmermann G, Granbichler CA, Kobulashvili T, Siebert U. Epidemiology of status epilepticus in adults: Apples, pears, and oranges - A critical review. Epilepsy Behav. 2020 Feb; 103(Pt A):106720. PMID: 31902646.
    Citations:    
  8. Sroczynski G, Esteban E, Widschwendter A, Oberaigner W, Borena W, von Laer D, Hackl M, Endel G, Siebert U. Reducing overtreatment associated with overdiagnosis in cervical cancer screening-A model-based benefit-harm analysis for Austria. Int J Cancer. 2019 Dec 24. PMID: 31872420.
    Citations:    
  9. Jahn B, Sroczynski G, Bundo M, Mühlberger N, Puntscher S, Todorovic J, Rochau U, Oberaigner W, Koffijberg H, Fischer T, Schiller-Fruehwirth I, Öfner D, Renner F, Jonas M, Hackl M, Ferlitsch M, Siebert U. Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria. BMC Gastroenterol. 2019 Dec 05; 19(1):209. PMID: 31805871.
    Citations:    
  10. Stella SF, Polanczyk CA, Arvandi M, Siebert U. Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil. Int J Qual Health Care. 2019 Nov 30; 31(9):676-681. PMID: 30576452.
    Citations:    Fields:    
  11. Gothe H, Rajsic S, Vukicevic D, Schoenfelder T, Jahn B, Geiger-Gritsch S, Brixner D, Popper N, Endel G, Siebert U. Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review. BMC Health Serv Res. 2019 Oct 22; 19(1):737. PMID: 31640678.
    Citations:    
  12. Spizzo G, Siebert U, Gastl G, Voss A, Schuster K, Leonard R, Seeber A. Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatment. Cost Eff Resour Alloc. 2019; 17:23. PMID: 31641338.
    Citations:    
  13. Klompmaker S, de Rooij T, Koerkamp BG, Shankar AH, Siebert U, Besselink MG, Moser AJ. International Validation of Reduced Major Morbidity After Minimally Invasive Distal Pancreatectomy Compared With Open Pancreatectomy. Ann Surg. 2019 Oct 17. PMID: 31756173.
    Citations:    
  14. Schomaker M, Kühne F, Siebert U. Re: "Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples with Apples". Am J Epidemiol. 2019 Sep 16. PMID: 31529036.
    Citations:    
  15. Kuehne F, Jahn B, Conrads-Frank A, Bundo M, Arvandi M, Endel F, Popper N, Endel G, Urach C, Gyimesi M, Murray EJ, Danaei G, Gaziano TA, Pandya A, Siebert U. Guidance for a causal comparative effectiveness analysis emulating a target trial based on big real world evidence: when to start statin treatment. J Comp Eff Res. 2019 Sep; 8(12):1013-1025. PMID: 31512926.
    Citations:    
  16. Miksch F, Jahn B, Espinosa KJ, Chhatwal J, Siebert U, Popper N. Why should we apply ABM for decision analysis for infectious diseases?-An example for dengue interventions. PLoS One. 2019; 14(8):e0221564. PMID: 31454373.
    Citations:    
  17. Ammenwerth E, Hoerbst A, Lannig S, Mueller G, Siebert U, Schnell-Inderst P. Effects of Adult Patient Portals on Patient Empowerment and Health-Related Outcomes: A Systematic Review. Stud Health Technol Inform. 2019 Aug 21; 264:1106-1110. PMID: 31438096.
    Citations:    
  18. Jahn B, Todorovic J, Bundo M, Sroczynski G, Conrads-Frank A, Rochau U, Endel G, Wilbacher I, Malbaski N, Popper N, Chhatwal J, Greenberg D, Mauskopf J, Siebert U. Budget Impact Analysis of Cancer Screening: A Methodological Review. Appl Health Econ Health Policy. 2019 08; 17(4):493-511. PMID: 31016686.
    Citations:    
  19. Jahn B, Kurzthaler C, Chhatwal J, Elbasha EH, Conrads-Frank A, Rochau U, Sroczynski G, Urach C, Bundo M, Popper N, Siebert U. Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness. Med Decis Making. 2019 07; 39(5):509-522. PMID: 31253053.
    Citations:    
  20. Sommer I, Titscher V, Teufer B, Klerings I, Nußbaumer-Streit B, Szelag M, Affengruber L, Wagner G, Glechner A, Kien C, Ebenberger A, Schiller-Frühwirth I, Dorner TE, Siebenhofer A, Haditsch B, Bachler H, Siebert U, Gartlehner G. [Evidence-based recommendations for the revision of the Austrian periodic health examination]. Wien Med Wochenschr. 2019 Oct; 169(13-14):339-349. PMID: 31187373.
    Citations:    
  21. Borba HHL, Rochau U, Wiens A, Sroczynski G, Siebert U, Ferreira VL, Minowa E, Pontarolo R. Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis From the Brazilian Public Health System Perspective. Value Health Reg Issues. 2019 Dec; 20:95-102. PMID: 31108456.
    Citations:    
  22. Latimer NR, Abrams KR, Siebert U. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring. BMC Med Res Methodol. 2019 03 29; 19(1):69. PMID: 30935369.
    Citations:    
  23. Adarkwah CC, Jegan N, Heinzel-Gutenbrunner M, Kühne F, Siebert U, Popert U, Donner-Banzhoff N, Kürwitz S. The Optimizing-Risk-Communication (OptRisk) randomized trial - impact of decision-aid-based consultation on adherence and perception of cardiovascular risk. Patient Prefer Adherence. 2019; 13:441-452. PMID: 30988601.
    Citations:    
  24. Morawetz D, Blank C, Koller A, Arvandi M, Siebert U, Schobersberger W. Sex-Related Differences After a Single Bout of Maximal Eccentric Exercise in Response to Acute Effects: A Systematic Review and Meta-analysis. J Strength Cond Res. 2019 Mar 15. PMID: 30908366.
    Citations:    
  25. Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up. Geburtshilfe Frauenheilkd. 2019 Feb; 79(2):160-176. PMID: 30792546.
    Citations:    
  26. Hillemanns P, Friese K, Dannecker C, Klug S, Seifert U, Iftner T, Hädicke J, Löning T, Horn L, Schmidt D, Ikenberg H, Steiner M, Freitag U, Siebert U, Sroczynski G, Sauerbrei W, Beckmann MW, Gebhardt M, Friedrich M, Münstedt K, Schneider A, Kaufmann A, Petry KU, Schäfer APA, Pawlita M, Weis J, Mehnert A, Fehr M, Grimm C, Reich O, Arbyn M, Kleijnen J, Wesselmann S, Nothacker M, Follmann M, Langer T, Jentschke M. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia. Geburtshilfe Frauenheilkd. 2019 Feb; 79(2):148-159. PMID: 30792545.
    Citations:    
  27. Kristensen FB, Husereau D, Huic M, Drummond M, Berger ML, Bond K, Augustovski F, Booth A, Bridges JFP, Grimshaw J, IJzerman MJ, Jonsson E, Ollendorf DA, Rüther A, Siebert U, Sharma J, Wailoo A. Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. Value Health. 2019 01; 22(1):13-20. PMID: 30661627.
    Citations:    Fields:    
  28. Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A, Kalss G, Neuray C, Kreidenhuber R, Höfler J, Kuchukhidze G, Granbichler C, Dobesberger J, Novak HF, Pilz G, Meletti S, Siebert U. Epidemiology of status epilepticus in adults: A population-based study on incidence, causes, and outcomes. Epilepsia. 2019 Jan; 60(1):53-62. PMID: 30478910.
    Citations:    Fields:    
  29. Velickovic VM, Borisenko O, Svensson M, Spelman T, Siebert U. Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model. PLoS One. 2018; 13(9):e0204643. PMID: 30261033.
    Citations:    Fields:    
  30. Velickovic VM, Rochau U, Conrads-Frank A, Kee F, Blankenberg S, Siebert U. Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays. Expert Rev Pharmacoecon Outcomes Res. 2018 12; 18(6):619-640. PMID: 30115001.
    Citations:    Fields:    Translation:Humans
  31. Siebert U, Hallsson LR. To stop or not to stop: a value of information view. Eur J Epidemiol. 2018 Sep; 33(9):785-787. PMID: 30120627.
    Citations:    Fields:    
  32. Völzke H, Erlund I, Hubalewska-Dydejczyk A, Ittermann T, Peeters RP, Rayman M, Buchberger M, Siebert U, Thuesen BH, Zimmermann MB, Grünert S, Lazarus JH. How Do We Improve the Impact of Iodine Deficiency Disorders Prevention in Europe and Beyond? Eur Thyroid J. 2018 Aug; 7(4):193-200. PMID: 30283737.
    Citations:    
  33. Latimer NR, White IR, Abrams KR, Siebert U. Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Stat Methods Med Res. 2019 08; 28(8):2475-2493. PMID: 29940824.
    Citations:    Fields:    
  34. Rajsic S, Gothe H, Borba HH, Sroczynski G, Vujicic J, Toell T, Siebert U. Economic burden of stroke: a systematic review on post-stroke care. Eur J Health Econ. 2019 Feb; 20(1):107-134. PMID: 29909569.
    Citations:    Fields:    
  35. Loeb S, Curnyn C, Walter D, Fagerlin A, Siebert U, Mühlberger N, Braithwaite RS, Schwartz MD, Lepor H, Sedlander E. Health state utilities among contemporary prostate cancer patients on active surveillance. Transl Androl Urol. 2018 Apr; 7(2):197-202. PMID: 29732277.
    Citations:    
  36. Richter AK, Klimek L, Merk HF, Mülleneisen N, Renz H, Wehrmann W, Werfel T, Hamelmann E, Siebert U, Sroczynski G, Wasem J, Biermann-Stallwitz J. Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach. Eur J Health Econ. 2018 Dec; 19(9):1229-1242. PMID: 29574666.
    Citations:    Fields:    
  37. Arvandi M, Strasser B, Volaklis K, Ladwig KH, Grill E, Matteucci Gothe R, Horsch A, Laxy M, Siebert U, Peters A, Thorand B, Meisinger C. Mediator Effect of Balance Problems on Association Between Grip Strength and Falls in Older Adults: Results From the KORA-Age Study. Gerontol Geriatr Med. 2018 Jan-Dec; 4:2333721418760122. PMID: 29568795.
    Citations:    
  38. Widschwendter M, Jones A, Evans I, Reisel D, Dillner J, Sundström K, Steyerberg EW, Vergouwe Y, Wegwarth O, Rebitschek FG, Siebert U, Sroczynski G, de Beaufort ID, Bolt I, Cibula D, Zikan M, Bjørge L, Colombo N, Harbeck N, Dudbridge F, Tasse AM, Knoppers BM, Joly Y, Teschendorff AE, Pashayan N. Epigenome-based cancer risk prediction: rationale, opportunities and challenges. Nat Rev Clin Oncol. 2018 05; 15(5):292-309. PMID: 29485132.
    Citations: 4     Fields:    
  39. Seidl A, Danner M, Wagner CJ, Sandmann FG, Sroczynski G, Stürzlinger H, Zsifkovits J, Schwalm A, Lhachimi SK, Siebert U, Gerber-Grote A. Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants. MDM Policy Pract. 2018 Jan-Jun; 3(1):2381468317751923. PMID: 30288435.
    Citations:    
  40. Schnell-Inderst P, Hunger T, Conrads-Frank A, Arvandi M, Siebert U. Recommendations for primary studies evaluating therapeutic medical devices were identified and systematically reported through reviewing existing guidance. J Clin Epidemiol. 2018 02; 94:46-58. PMID: 29122699.
    Citations:    Fields:    
  41. Schnell-Inderst P, Hunger T, Conrads-Frank A, Arvandi M, Siebert U. Ten recommendations for assessing the comparative effectiveness of therapeutic medical devices: a targeted review and adaptation. J Clin Epidemiol. 2018 02; 94:97-113. PMID: 29107757.
    Citations: 1     Fields:    
  42. Jahn B, Rochau U, Kurzthaler C, Hubalek M, Miksad R, Sroczynski G, Paulden M, Bundo M, Stenehjem D, Brixner D, Krahn M, Siebert U. Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online. BMC Cancer. 2017 Oct 16; 17(1):685. PMID: 29037213.
    Citations:    Fields:    Translation:Humans
  43. Jahn B, Arvandi M, Rochau U, Fiegl H, Goebel G, Marth C, Siebert U. Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1. J Comp Eff Res. 2017 Oct; 6(7):563-574. PMID: 29091014.
    Citations: 1     Fields:    
  44. Loeb S, Zhou Q, Siebert U, Rochau U, Jahn B, Mühlberger N, Carter HB, Lepor H, Braithwaite RS. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions. Eur Urol. 2017 12; 72(6):899-907. PMID: 28844371.
    Citations: 2     Fields:    Translation:Humans
  45. Christensen KD, Uhlmann WR, Roberts JS, Linnenbringer E, Whitehouse PJ, Royal CDM, Obisesan TO, Cupples LA, Butson MB, Fasaye GA, Hiraki S, Chen CA, Siebert U, Cook-Deegan R, Green RC. A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone. Genet Med. 2018 01; 20(1):132-141. PMID: 28726810.
    Citations: 2     Fields:    Translation:Humans
  46. Mühlberger N, Boskovic K, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Sroczynski G, Siebert U. Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model. BMC Public Health. 2017 06 26; 17(1):596. PMID: 28651567.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  47. Schiller-Frühwirth IC, Jahn B, Arvandi M, Siebert U. Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review. Appl Health Econ Health Policy. 2017 Jun; 15(3):333-351. PMID: 28185134.
    Citations: 1     Fields:    Translation:Humans
  48. Schiller-Fruehwirth I, Jahn B, Einzinger P, Zauner G, Urach C, Siebert U. The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria. Value Health. 2017 09; 20(8):1048-1057. PMID: 28964436.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  49. Di Paolo A, Sarkozy F, Ryll B, Siebert U. Personalized medicine in Europe: not yet personal enough? BMC Health Serv Res. 2017 Apr 19; 17(1):289. PMID: 28424057.
    Citations: 1     Fields:    Translation:Humans
  50. Oberaigner W, Geiger-Gritsch S, Edlinger M, Daniaux M, Knapp R, Hubalek M, Siebert U, Marth C, Buchberger W. Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria. Breast. 2017 Jun; 33:178-182. PMID: 28419909.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  51. Bose-O'Reilly S, Bernaudat L, Siebert U, Roider G, Nowak D, Drasch G. Signs and symptoms of mercury-exposed gold miners. Int J Occup Med Environ Health. 2017 Mar 30; 30(2):249-269. PMID: 28366955.
    Citations:    Fields:    Translation:HumansPHPublic Health
  52. Czarnecka-Kujawa K, Rochau U, Siebert U, Atenafu E, Darling G, Waddell TK, Pierre A, De Perrot M, Cypel M, Keshavjee S, Yasufuku K. Cost-effectiveness of mediastinal lymph node staging in non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017 06; 153(6):1567-1578. PMID: 28283236.
    Citations: 1     Fields:    
  53. Schnell-Inderst P, Iglesias CP, Arvandi M, Ciani O, Matteucci Gothe R, Peters J, Blom AW, Taylor RS, Siebert U. A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement. Health Econ. 2017 02; 26 Suppl 1:46-69. PMID: 28139089.
    Citations:    Fields:    Translation:Humans
  54. Arvandi M, Strasser B, Meisinger C, Volaklis K, Gothe RM, Siebert U, Ladwig KH, Grill E, Horsch A, Laxy M, Peters A, Thorand B. Gender differences in the association between grip strength and mortality in older adults: results from the KORA-age study. BMC Geriatr. 2016 11 30; 16(1):201. PMID: 27903239.
    Citations: 6     Fields:    Translation:Humans
  55. Adarkwah CC, Jegan N, Heinzel-Gutenbrunner M, Kühne F, Siebert U, Popert U, Donner-Banzhoff N, Kürwitz S. Time-to-event versus ten-year-absolute-risk in cardiovascular risk prevention - does it make a difference? Results from the Optimizing-Risk-Communication (OptRisk) randomized-controlled trial. BMC Med Inform Decis Mak. 2016 11 29; 16(1):152. PMID: 27899103.
    Citations: 1     Fields:    Translation:Humans
  56. Hunger T, Schnell-Inderst P, Sahakyan N, Siebert U. USING EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT: A GUIDELINE REVIEW. Int J Technol Assess Health Care. 2016 Jan; 32(3):131-9. PMID: 27502308.
    Citations: 1     Fields:    
  57. Dams J, Balzer-Geldsetzer M, Siebert U, Deuschl G, Schuepbach WM, Krack P, Timmermann L, Schnitzler A, Reese JP, Dodel R. Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications. Mov Disord. 2016 08; 31(8):1183-91. PMID: 27506638.
    Citations: 3     Fields:    Translation:Humans
  58. Bose-O'Reilly S, Schierl R, Nowak D, Siebert U, William JF, Owi FT, Ir YI. A preliminary study on health effects in villagers exposed to mercury in a small-scale artisanal gold mining area in Indonesia. Environ Res. 2016 08; 149:274-281. PMID: 27174690.
    Citations: 3     Fields:    Translation:HumansAnimalsPHPublic Health
  59. Willenbacher E, Weger R, Rochau U, Siebert U, Willenbacher W. Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics. PLoS One. 2016; 11(3):e0147381. PMID: 26937956.
    Citations: 4     Fields:    Translation:Humans
  60. Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote A, Greiner W, Hanquet G, Hutubessy R, Jit M, Knol M, von Kries R, Kuhlmann A, Levy-Bruhl D, Perleth M, Postma M, Salo H, Siebert U, Wasem J, Wichmann O. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. Pharmacoeconomics. 2016 Mar; 34(3):227-44. PMID: 26477039.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  61. Völzke H, Caron P, Dahl L, de Castro JJ, Erlund I, Gaberšcek S, Gunnarsdottir I, Hubalewska-Dydejczyk A, Ittermann T, Ivanova L, Karanfilski B, Khattak RM, Kusic Z, Laurberg P, Lazarus JH, Markou KB, Moreno-Reyes R, Nagy EV, Peeters RP, Pirags V, Podoba J, Rayman MP, Rochau U, Siebert U, Smyth PP, Thuesen BH, Troen A, Vila L, Vitti P, Zamrazil V, Zimmermann MB. Ensuring Effective Prevention of Iodine Deficiency Disorders. Thyroid. 2016 Feb; 26(2):189-96. PMID: 26700864.
    Citations: 3     Fields:    Translation:Humans
  62. Luzak A, Schnell-Inderst P, Bühn S, Mayer-Zitarosa A, Siebert U. Clinical effectiveness of cancer screening biomarker tests offered as self-pay health service: a systematic review. Eur J Public Health. 2016 06; 26(3):498-505. PMID: 26733629.
    Citations:    Fields:    Translation:Humans
  63. Latimer NR, Henshall C, Siebert U, Bell H. TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES. Int J Technol Assess Health Care. 2016 Jan; 32(3):160-6. PMID: 27624982.
    Citations: 2     Fields:    Translation:Humans
  64. Christensen KD, Dukhovny D, Siebert U, Green RC. Assessing the Costs and Cost-Effectiveness of Genomic Sequencing. J Pers Med. 2015 Dec 10; 5(4):470-86. PMID: 26690481.
    Citations: 21     
  65. Rochau U, Kluibenschaedl M, Stenehjem D, Kuan-Ling K, Radich J, Oderda G, Brixner D, Siebert U. Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis. Leuk Res Treatment. 2015; 2015:982395. PMID: 26783469.
    Citations: 2     
  66. Jahn B, Rochau U, Kurzthaler C, Hubalek M, Miksad R, Sroczynski G, Paulden M, Kluibenschädl M, Krahn M, Siebert U. Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria. Springerplus. 2015; 4:752. PMID: 26693110.
    Citations: 2     
  67. Stenehjem DD, Bellows BK, Yager KM, Jones J, Kaldate R, Siebert U, Brixner DI. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer. Oncologist. 2016 Feb; 21(2):196-204. PMID: 26614710.
    Citations: 1     Fields:    Translation:Humans
  68. Rochau U, Vukicevic D, Schmidt S, Stenehjem D, Brixner D, Radich J, Gastl G, Siebert U. COST-EFFECTIVENESS ANALYSIS ON STARTING PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB. Value Health. 2015 Nov; 18(7):A462. PMID: 26532598.
    Citations:    Fields:    
  69. Buchberger M, Rochau U, Vukicevic D, Willenbacher W, Siebert U. TREATMENT STRATEGIES FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A META-ANALYSIS AND INDIRECT TREATMENT COMPARISON. Value Health. 2015 Nov; 18(7):A432. PMID: 26532434.
    Citations:    Fields:    
  70. Jahn B, Rochau U, Kurzthaler C, Paulden M, Kluibenschädl M, Arvandi M, Kühne F, Goehler A, Krahn MD, Siebert U. Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment. Med Decis Making. 2016 04; 36(3):375-90. PMID: 26476865.
    Citations: 3     Fields:    Translation:Humans
  71. Schwarzer R, Rochau U, Saverno K, Jahn B, Bornschein B, Muehlberger N, Flatscher-Thoeni M, Schnell-Inderst P, Sroczynski G, Lackner M, Schall I, Hebborn A, Pugner K, Fehervary A, Brixner D, Siebert U. Systematic overview of cost-effectiveness thresholds in ten countries across four continents. J Comp Eff Res. 2015 Sep; 4(5):485-504. PMID: 26490020.
    Citations: 6     Fields:    Translation:Humans
  72. Gothe H, Schall I, Saverno K, Mitrovic M, Luzak A, Brixner D, Siebert U. The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review. Appl Health Econ Health Policy. 2015 Aug; 13 Suppl 1:S21-33. PMID: 26091709.
    Citations: 6     Fields:    Translation:Humans
  73. Siebert U, Jahn B, Rochau U, Schnell-Inderst P, Kisser A, Hunger T, Sroczynski G, Mühlberger N, Willenbacher W, Schnaiter S, Endel G, Huber L, Gastl G. Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research. Z Evid Fortbild Qual Gesundhwes. 2015; 109(4-5):330-40. PMID: 26354133.
    Citations: 1     Fields:    Translation:Humans
  74. Schnell-Inderst P, Mayer J, Lauterberg J, Hunger T, Arvandi M, Conrads-Frank A, Nachtnebel A, Wild C, Siebert U. Health technology assessment of medical devices: What is different? An overview of three European projects. Z Evid Fortbild Qual Gesundhwes. 2015; 109(4-5):309-18. PMID: 26354131.
    Citations: 3     Fields:    Translation:Humans
  75. Leichtfried V, Basic D, Burtscher M, Gothe RM, Siebert U, Schobersberger W. Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation--independent of absolute altitude? Sleep Breath. 2016 Mar; 20(1):435-42. PMID: 26032284.
    Citations: 2     Fields:    Translation:Humans
  76. Mühlberger N, Kurzthaler C, Iskandar R, Krahn MD, Bremner KE, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U. The ONCOTYROL Prostate Cancer Outcome and Policy Model: Effect of Prevalence Assumptions on the Benefit-Harm Balance of Screening. Med Decis Making. 2015 08; 35(6):758-72. PMID: 25977360.
    Citations: 2     Fields:    Translation:Humans
  77. Geiger-Gritsch S, Oberaigner W, Mühlberger N, Siebert U, Ladurner M, Klocker H, Horninger W. Patient-reported urinary incontinence and erectile dysfunction following radical prostatectomy: results from the European Prostate Centre Innsbruck. Urol Int. 2015; 94(4):419-27. PMID: 25662301.
    Citations: 1     Fields:    Translation:Humans
  78. Rochau U, Sroczynski G, Wolf D, Schmidt S, Jahn B, Kluibenschaedl M, Conrads-Frank A, Stenehjem D, Brixner D, Radich J, Gastl G, Siebert U. Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. Leuk Lymphoma. 2015; 56(8):2315-25. PMID: 25393806.
    Citations: 7     Fields:    Translation:Humans
  79. Rogowski W, Payne K, Schnell-Inderst P, Manca A, Rochau U, Jahn B, Alagoz O, Leidl R, Siebert U. Concepts of 'personalization' in personalized medicine: implications for economic evaluation. Pharmacoeconomics. 2015 Jan; 33(1):49-59. PMID: 25249200.
    Citations: 16     Fields:    Translation:Humans
  80. Rochau U, Jahn B, Qerimi V, Burger EA, Kurzthaler C, Kluibenschaedl M, Willenbacher E, Gastl G, Willenbacher W, Siebert U. Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example. Crit Rev Oncol Hematol. 2015 May; 94(2):164-78. PMID: 25620327.
    Citations: 2     Fields:    Translation:Humans
  81. Steckling N, Bose-O'Reilly S, Pinheiro P, Plass D, Shoko D, Drasch G, Bernaudat L, Siebert U, Hornberg C. The burden of chronic mercury intoxication in artisanal small-scale gold mining in Zimbabwe: data availability and preliminary estimates. Environ Health. 2014 Dec 13; 13:111. PMID: 25495641.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  82. Oostvogels AJ, De Wit GA, Jahn B, Cassini A, Colzani E, De Waure C, Kretzschmar ME, Siebert U, Mühlberger N, Mangen MJ. Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review. Epidemiol Infect. 2015 Jul; 143(9):1791-802. PMID: 25499823.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  83. Neumann A, Mostardt S, Biermann J, Gelbrich G, Goehler A, Geisler BP, Siebert U, Störk S, Ertl G, Angerrmann CE, Wasem J. Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study. Clin Res Cardiol. 2015 Apr; 104(4):304-9. PMID: 25403774.
    Citations: 4     Fields:    Translation:Humans
  84. Rochau U, Schnell-Inderst P, Burger EA, Baldauf M, Kühne F, Jahn B, Siebert U. Systematic Overview On Value-Of Information Analyses In Cancer Research. Value Health. 2014 Nov; 17(7):A559. PMID: 27201842.
    Citations:    Fields:    
  85. Hunger T, Schnell-Inderst P, Arvandi M, Conrads-Frank A, Siebert U. Comparative Effectiveness Research of Medical Devices - New Methods Needed? Value Health. 2014 Nov; 17(7):A582. PMID: 27201970.
    Citations:    Fields:    
  86. Jahn B, Rochau U, Shterjovska J, Kurzthaler C, Kluibenschädl M, Urach C, Einzinger P, Piringer H, Popper N, Siebert U. Visualizing Methods For Discrete-Event-Simulations Using The Example Of A Breast Cancer Decision-Analytic Model. Value Health. 2014 Nov; 17(7):A562. PMID: 27201856.
    Citations:    Fields:    
  87. Kuehne F, Rochau U, Paracha N, Sabate E, Siebert U. Estimating Crossover Bias In A Randomized Clinical Trial Of Ovarian Cancer Treatment. Value Health. 2014 Nov; 17(7):A564. PMID: 27201868.
    Citations:    Fields:    
  88. Rochau U, Kluibenschaedl M, Stenehjem D, Kuo KL, Oderda G, Brixner D, Siebert U. Decision Analysis on the Cost-Effectiveness of Sequential Treatment Strategies for Patients with Chronic Myeloid Leukemia in the United States. Value Health. 2014 Nov; 17(7):A639. PMID: 27202283.
    Citations:    Fields:    
  89. Mühlberger N, Heijnsdijk EA, Kurzthaler C, Iskandar R, Krahn MD, Bremner K, Oberaigner W, Klocker H, Horninger W, Conrads-Frank A, Sroczynski G, Siebert U. The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening. Value Health. 2014 Nov; 17(7):A559. PMID: 27201843.
    Citations:    Fields:    
  90. Ultsch B, Damm O, Beutels P, Bilcke J, Brüggenjürgen B, Gerber-Grote AU, Greiner W, Hanquet G, Harder T, Hutubessy R, Jit M, Knol M, Kuhlmann A, von Kries R, Levy-Bruhl D, Perleth M, Postma MJ, Salo H, Siebert U, Wasem J, Weidemann F, Wichmann O. Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop. Value Health. 2014 Nov; 17(7):A552. PMID: 27201800.
    Citations: 1     Fields:    
  91. Rochau U, Kühne F, Jahn B, Kurzthaler C, Corro RI, Chhatwal J, Stollenwerk B, Goldhaber-Fiebert JD, Siebert U. Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis. Value Health. 2014 Nov; 17(7):A639. PMID: 27202284.
    Citations:    Fields:    
  92. Glogger M, Schnell-Inderst P, Luzak A, Krueger A, Siebert U. New Reimbursement Schemes for Stratified Medicine in Oncology - A Systematic Review. Value Health. 2014 Nov; 17(7):A663. PMID: 27202420.
    Citations:    Fields:    
  93. Diaby V, Goeree R, Hoch J, Siebert U. Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion. Expert Rev Pharmacoecon Outcomes Res. 2015 Feb; 15(1):13-9. PMID: 25267699.
    Citations: 1     Fields:    Translation:Humans
  94. Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, Ruijter Hd, Schnabel RB, Kee F, Salomaa V, Siebert U, Thorand B, Ziegler A, Breek H, Pasterkamp G, Kuulasmaa K, Koenig W, Blankenberg S. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol. 2014 Oct; 29(10):777-90. PMID: 25238720.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  95. Rochau U, Schwarzer R, Jahn B, Sroczynski G, Kluibenschaedl M, Wolf D, Radich J, Brixner D, Gastl G, Siebert U. Systematic assessment of decision-analytic models for chronic myeloid leukemia. Appl Health Econ Health Policy. 2014 Apr; 12(2):103-15. PMID: 24385259.
    Citations: 1     Fields:    Translation:Humans
  96. Williams R, Kelly N, Boebel O, Friedlaender AS, Herr H, Kock KH, Lehnert LS, Maksym T, Roberts J, Scheidat M, Siebert U, Brierley AS. Counting whales in a challenging, changing environment. Sci Rep. 2014 Mar 13; 4:4170. PMID: 24622821.
    Citations: 1     Fields:    Translation:Animals
  97. Stollenwerk B, Lhachimi SK, Briggs A, Fenwick E, Caro JJ, Siebert U, Danner M, Gerber-Grote A. Communicating the parameter uncertainty in the IQWiG efficiency frontier to decision-makers. Health Econ. 2015 Apr; 24(4):481-90. PMID: 24590819.
    Citations:    Fields:    Translation:Humans
  98. Saverno K, Gothe H, Schuessel K, Biskupiak J, Schulz M, Siebert U, Brixner D. Consideration of international generic distribution policies on patient outcomes in the United States and Germany. Pharmazie. 2014 Mar; 69(3):238-40. PMID: 24716417.
    Citations: 2     Fields:    Translation:Humans
  99. Obach D, Deuffic-Burban S, Esmat G, Anwar WA, De